Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer-Reference-Cited by-同舟云学术

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer

Published:2023-04 Issue: Volume:46 Page:101156
ISSN:2352-5789
Container-title:Gynecologic Oncology Reports
language:en
Short-container-title:Gynecologic Oncology Reports

Author:

Piver Rachael N.,Wagner Vincent M.,Levine Monica D.,Backes Floor J.,Chambers Laura J.,Cohn David E.,Copeland Larry J.,Cosgrove Casey M.,Nagel Christa I.,O'Malley David M.,Bixel Kristin L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference18 articles.

1. Epidemiology and risk factors of venous thromboembolism;Ageno;Semin. Thromb. Hemost.,2006

2. Risk factors for venous thromboembolism;Anderson;Circulation.,2003

3. Retrospective cohort study of venous thromboembolism rates in ambulatory cancer patients: association with Khorana score and other risk factors;Austin;J. Hematol.,2019

4. The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients;Barber;Am. J. Obstet. Gynecol.,2016

5. AVERT investigators, Apixaban to prevent venous thromboembolism in patients with cancer;Carrier;N. Engl. J. Med.,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer;Gynecologic Oncology;2024-09

2. Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients;International Journal of Gynecologic Cancer;2024-07-13

3. Assessing hypercoagulability and VTE risk using thromboelastography and Khorana score in women with cancers receiving chemotherapy;American Journal of Hematology;2024-02-29

4. Novel Insights in Venous Thromboembolism Risk Assessment Methods in Ambulatory Cancer Patients: From the Guidelines to Clinical Practice;Cancers;2024-01-21

5. Predicting Vte and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer;2024